Medical Innovation Insights
The past year has highlighted both the tragic human cost of the pandemic and the remarkable speed of medical innovation, particularly with mRNA vaccines. Despite the challenges of inequity in access to healthcare, the dedication of scientists has led to unprecedented advancements in vaccine development. Moving forward, a stronger presence in policy-making is essential to ensure that the market's needs are understood and addressed.In this clip
From this podcast
Masters of Scale
Rapid Response: How mission fuels risk-taking, with Illumina CEO Francis deSouza
Related Questions